Baseline and cycle characteristics of patients in the GH and control groups before and after PSM
RPL
RECURRENT PREGNANCY LOSS, PREGNANCY LOSS
A total of 692 women with AMA undergoing PGT-A were included in this study, including 143 in the GH group and 549 in the control group (Fig. 
Flowchart detailing the distribution of the two study groups. GH = growth hormone; OS = ovarian stimulation; PGT-A = preimplantation genetic screening; PS = propensity score; SET = single embryo transfer
Baseline and cycle characteristics of the GH and control groups before/after propensity score matchingGH = growth hormone; PSM = propensity score matching; BMI = body mass index; OS = ovarian stimulation; PGT-A = preimplantation genetic screening; AMA = advanced maternal age; PL = pregnancy loss; RIF = repeated implantation failure; RPL = recurrent pregnancy loss; FSH = follicle stimulating hormone; LH = luteinizing hormone; E2 = estradiol; AMH = anti-Mullerian hormone; AFC = antral follicle count; PN = pronuclei.